Quest Diagnostics(DGX) - 2025 Q3 - Earnings Call Presentation

Q3 2025 Performance Robust growth and strong demand for our clinical solutions enables Quest to again raise full year 2025 guidance Q3 2025 13.1% Total revenue $2.82 billion Adjusted operating Adjusted diluted EPS2 $2.60 per share 16.3% 13.0% 1,3 Company overview Quest is a leader in diagnostic testing insights and information services. Read our Q3 earnings press release on our Investor Relations site. We delivered another quarter of robust top- and bottom-line growth, underscoring strong demand for our cli ...